Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Jun 30, 2025 | (Q2)Mar 31, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 67.91%-3.65K | 85.29%-4.53K | -180.82%-2.5K | 94.67%-38.99K | 100.06%60 | 30.57%-11.38K | 69.14%-30.76K | 100.59%3.09K | -172.90%-732.15K | -248.59%-95.37K |
| Net income from continuing operations | 29.61%-46.81K | 17.01%-53.76K | 43.57%-45.93K | 67.14%-274.89K | 52.91%-62.2K | 62.62%-66.51K | 60.11%-64.78K | 77.65%-81.4K | -4.57%-836.67K | 45.53%-132.1K |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---13.09K | --0 |
| Remuneration paid in stock | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -73.54%121.57K | --0 |
| Change In working capital | -21.71%43.16K | 44.74%49.24K | -48.60%43.43K | 6,051.01%235.9K | 69.53%62.26K | -65.87%55.13K | -55.14%34.02K | 130.39%84.49K | -119.54%-3.96K | -18.09%36.72K |
| -Change in receivables | -102.77%-340 | 50.09%-1.34K | -96.68%1.6K | 373.15%54.05K | 70.13%-3.67K | 1,372.59%12.26K | -134.00%-2.68K | 990.55%48.14K | -43.87%-19.79K | -373.43%-12.28K |
| -Change in prepaid assets | --0 | -93.81%385 | --0 | 199.15%44.68K | -85.22%9.4K | -99.83%200 | -92.09%6.22K | 109.51%28.87K | -2,153.20%-45.06K | 3,079.65%63.59K |
| -Change in payables and accrued expense | 1.94%43.5K | 64.67%50.19K | 459.03%41.83K | 125.27%137.17K | 487.37%56.53K | -7.94%42.68K | 1,947.09%30.48K | -75.69%7.48K | 68.96%60.89K | -132.12%-14.59K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 67.91%-3.65K | 85.29%-4.53K | -180.82%-2.5K | 94.67%-38.99K | 100.06%60 | 30.57%-11.38K | 69.14%-30.76K | 100.59%3.09K | -172.90%-732.15K | -248.59%-95.37K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 98.86%-150 | -151.35%-24.62K | -107.74%-10.39K | 0 | -2,252.27%-1.04K | -177.79%-13.2K | 95.34%-9.79K | 90.38%-5K |
| Net PPE purchase and sale | ---- | --0 | 98.86%-150 | -151.35%-24.62K | -107.74%-10.39K | --0 | -2,252.27%-1.04K | -177.79%-13.2K | 95.34%-9.79K | 90.38%-5K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | 98.86%-150 | -151.35%-24.62K | -107.74%-10.39K | --0 | -2,252.27%-1.04K | -177.79%-13.2K | 95.34%-9.79K | 90.38%-5K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 0 | 200.18%652.3K | -27.17%100K | |||||
| Net common stock issuance | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 128.72%497K | --100K |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --162.2K | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---6.9K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 200.18%652.3K | -27.17%100K |
| Net cash flow | ||||||||||
| Beginning cash position | -67.53%13.89K | -75.31%18.41K | -75.12%21.06K | -51.43%84.67K | -63.09%31.39K | -57.83%42.77K | -62.93%74.57K | -51.43%84.67K | -59.95%174.31K | -26.89%85.04K |
| Current changes in cash | 67.91%-3.65K | 85.77%-4.53K | 73.78%-2.65K | 29.04%-63.61K | -2,668.63%-10.33K | 30.57%-11.38K | 68.11%-31.8K | -137.64%-10.1K | 65.65%-89.64K | -100.64%-373 |
| End cash Position | -67.39%10.24K | -67.53%13.89K | -75.31%18.41K | -75.12%21.06K | -75.12%21.06K | -63.09%31.39K | -57.83%42.77K | -62.93%74.57K | -51.43%84.67K | -51.43%84.67K |
| Free cash from | -222.80%-3.5K | 85.77%-4.53K | 73.78%-2.65K | 91.43%-63.61K | 75.53%-24.56K | 117.40%2.85K | 68.11%-31.8K | 98.08%-10.1K | -55.14%-741.94K | -26.54%-100.37K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.